Pentobarbital will minimize the extent or result of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Coadministration of fentanyl with CYP3A4 inducers may lead to your lower in fentanyl plasma concentrations, not enough efficacy or, probably, growth of the withdrawal syndrome within a affected person https://anniea332vjw8.plpwiki.com/user